DARZALEX, Continues

DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance | DelveInsight

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United Kingdom United States of America

 
+14699457679

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/darzalex-continues-to-redefine-multiple-myeloma-treatment-with-robust-market-performance--delveinsight-302406653.html

en | boerse | 67925976 |